Dexcom Announces Upcoming Conference Presentation
SAN DIEGO--(BUSINESS WIRE)--Dec 18, 2018--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference:Kevin Sayer, Chairman, Chief Executive Officer and President, will present an update on the company at the J.P. Morgan 37th Annual Healthcare Conference in San Francisco, California on Monday, January 7, 2019 at 8:00am (PST). The presentation, which will occur live at the Westin St. Francis Hotel, will be concurrently webcast.
The link to the webcast will be available on the Dexcom website at www.dexcom.com by navigating to “About Us,” then “Investor Relations,” and finally “Events and Presentations” and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181218005784/en/
CONTACT: DexCom, Inc.
Steven R. Pacelli
Executive Vice President, Strategy and Corporate Development
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES DIABETES
SOURCE: DexCom, Inc.
Copyright Business Wire 2018.
PUB: 12/18/2018 04:01 PM/DISC: 12/18/2018 04:01 PM